Literature DB >> 11386986

Incidence of cancer among persons with schizophrenia and their relatives.

D Lichtermann1, J Ekelund, E Pukkala, A Tanskanen, J Lönnqvist.   

Abstract

BACKGROUND: It has repeatedly been reported that the risk for cancer in patients with schizophrenia is different from that of the general population, specifically a lower risk for lung cancer despite increased smoking. Confirmation of these associations could lead to hypotheses on shared risk or protective factors, either genetic or environmental.
METHODS: From Finland's National Hospital Discharge and Disability Pension registers, Helsinki, we identified a cohort of 26 996 individuals born between 1940 and 1969 and treated for schizophrenia between 1969 and 1991. They were followed up for cancer from 1971 to 1996 by record linkage with the Finnish Cancer Registry, yielding 446 653 person-years at risk, and standardized incidence ratios (SIRs) were calculated. Likewise, 39 131 parents and 52 976 siblings of the patients with schizophrenia were followed up to explore familial genetic hypotheses on deviations in cancer risk.
RESULTS: In patients with schizophrenia, an increased overall cancer risk was found (724 cases observed vs 619 expected; SIR, 1.17; 95% confidence interval [CI], 1.09-1.25). Half of the excess cases were attributable to lung cancer (SIR, 2.17; 95% CI, 1.78-2.60), and the strongest relative increase in risk was in pharyngeal cancer (SIR, 2.60; 95% CI, 1.25-4.77). Cancer incidence in siblings (SIR, 0.89; 95% CI, 0.83-0.94) and parents (SIR, 0.91; 95% CI, 0.89-0.93) was consistently lower than that in the general population.
CONCLUSION: Although specific lifestyle factors, particularly tobacco smoking and alcohol consumption, probably account for the increased cancer risk in patients with schizophrenia, the decreased risk in relatives would be compatible with a postulated genetic risk factor for schizophrenia offering selective advantage to unaffected relatives.

Entities:  

Mesh:

Year:  2001        PMID: 11386986     DOI: 10.1001/archpsyc.58.6.573

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  74 in total

1.  Physical Health and Dual Diagnosis.

Authors:  Debbie Robson; Sarah Keen; Pia Mauro
Journal:  Adv Dual Diagn       Date:  2008

2.  Ten critical reasons for treating tobacco dependence in inpatient psychiatry.

Authors:  Judith J Prochaska
Journal:  J Am Psychiatr Nurses Assoc       Date:  2009-12       Impact factor: 2.385

3.  Addressing nicotine dependence in psychodynamic psychotherapy: perspectives from residency training.

Authors:  Judith J Prochaska; Sebastien C Fromont; Peter Banys; Stuart J Eisendrath; Mardi J Horowitz; Marc H Jacobs; Sharon M Hall
Journal:  Acad Psychiatry       Date:  2007 Jan-Feb

4.  Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study.

Authors:  Giovanni Perini; Laura Grigoletti; Batul Hanife; Annibale Biggeri; Michele Tansella; Francesco Amaddeo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-10-05       Impact factor: 4.328

5.  Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia.

Authors:  Ke-Sheng Wang; Lingjun Zuo; Daniel Owusu; Yue Pan; Xingguang Luo
Journal:  J Schizophr Res       Date:  2014-08-01

Review 6.  Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?

Authors:  Judith J Prochaska; Sharon M Hall; Lisa A Bero
Journal:  Schizophr Bull       Date:  2007-11-05       Impact factor: 9.306

7.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

Review 8.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.

Authors:  Katherine E Burdick; Pamela DeRosse; John M Kane; Todd Lencz; Anil K Malhotra
Journal:  Am J Psychiatry       Date:  2010-01-15       Impact factor: 18.112

10.  Is Schizophrenia a Risk Factor for Breast Cancer?-Evidence From Genetic Data.

Authors:  Enda M Byrne; Manuel A R Ferreira; Angli Xue; Sara Lindström; Xia Jiang; Jian Yang; Douglas F Easton; Naomi R Wray; Georgia Chenevix-Trench
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.